Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-14 9:00 pm Sale | 13G | AMICUS THERAPEUTICS INC. FOLD | Redmile Group LLC | 15,376,197 5.100% | -6,581,729 (-29.97%) | View |
2024-11-14 9:00 pm Purchase | 13G | IMMUNOME INC IMNM | Redmile Group LLC | 4,889,554 8.100% | 1,010,139 (+26.04%) | View |
2024-11-14 9:00 pm Sale | 13G | KRYSTAL BIOTECH INC KRYS | Redmile Group LLC | 810,245 2.800% | -922,944 (-53.25%) | View |
2024-11-14 9:00 pm Purchase | 13G | PLIANT THERAPEUTICS INC PLRX | Redmile Group LLC | 3,197,491 5.300% | 500,843 (+18.57%) | View |
2024-11-14 9:00 pm Purchase | 13G | Scholar Rock Holding Corp SRRK | Redmile Group LLC | 8,301,187 9.900% | 594,304 (+7.71%) | View |
2024-11-14 9:00 pm Purchase | 13G | Stoke Therapeutics Inc. STOK | Redmile Group LLC | 4,713,509 9.000% | 2,088,003 (+79.53%) | View |
2024-11-14 9:00 pm Sale | 13G | ZYMEWORKS INC ZYME | Redmile Group LLC | 5,101,911 7.200% | -688,319 (-11.89%) | View |
2024-11-14 9:00 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 15,669,217 16.200% | 340,900 (+2.22%) | View |
2024-11-14 9:00 pm Purchase | 13G | Nurix Therapeutics Inc. NRIX | Redmile Group LLC | 6,970,307 9.900% | 1,948,421 (+38.80%) | View |
2024-11-14 9:00 pm Purchase | 13G | REGENXBIO INC RGNX | Redmile Group LLC | 4,942,312 9.900% | 1,181,622 (+31.42%) | View |
2024-11-14 9:00 pm Sale | 13G | REPARE THERAPEUTICS INC RPTX | Redmile Group LLC | 1,942,555 4.600% | -206,193 (-9.60%) | View |
2024-10-04 5:00 pm Sale | 13D | Augmedix Inc. AUGX | Redmile Group LLC | 0 0.000% | -22,131,580 (Position Closed) | View |
2024-09-13 4:01 pm Sale | 13G | Atara Biotherapeutics Inc. ATRA | Redmile Group LLC | 579,541 9.900% | -9,721,868 (-94.37%) | View |
2024-07-19 7:45 pm Purchase | 13D | Augmedix Inc. AUGX | Redmile Group LLC | 22,131,580 40.500% | 39,369 (+0.18%) | View |
2024-03-25 5:15 pm Purchase | 13D | FATE THERAPEUTICS INC FATE | Redmile Group LLC | 17,619,095 14.900% | 2,569,256 (+17.07%) | View |
2024-03-13 5:15 pm Sale | 13D | Science 37 Holdings Inc. SNCE | Redmile Group LLC | 0 0.000% | -994,529 (Position Closed) | View |
2024-03-05 5:15 pm Purchase | 13D | ABSCI CORP ABSI | Redmile Group LLC | 8,282,016 7.400% | 250,922 (+3.12%) | View |
2024-02-14 4:26 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Redmile Group LLC | 15,328,317 18.800% | 1,763,068 (+13.00%) | View |
2024-02-14 4:26 pm Sale | 13G | ALX ONCOLOGY HOLDINGS INC ALXO | Redmile Group LLC | 4,909,264 9.600% | -82,281 (-1.65%) | View |
2024-02-14 4:26 pm Sale | 13G | Akero Therapeutics Inc. AKRO | Redmile Group LLC | 1,109,476 2.000% | -1,523,436 (-57.86%) | View |